Coral Genomics

Coral Genomics developed innovative clinical laboratory tests designed to predict the most effective treatments for autoimmune diseases by integrating molecular, functional, and clinical data. Their approach aimed to provide personalized treatment strategies, optimizing patient outcomes and reducing the trial-and-error often associated with autoimmune disease management. Furthermore, Coral Genomics identified a specific subpopulation of patients who exhibit resistance to existing therapies, focusing their efforts on developing solutions to address this significant unmet medical need within the autoimmune disease landscape.